During the past decade, Asahikawa-Kosei General Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asahikawa-Kosei General Hospital" #1 collaborator was "Korean Cancer Study Group" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Asahikawa-Kosei General Hospital" are "Anemia" (2 trials), "Gastric Cancer" (2 trials), "Renal Insufficiency, Chronic" (2 trials) and "Advanced Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Asahikawa-Kosei General Hospital" in a lesser frequency.

Most popular intervention types in "Asahikawa-Kosei General Hospital" are "Drug" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Molidustat (BAY85-3934)" (2 trials), "Darbepoetin alfa" (1 trials), "Placebo" (1 trials), "Placebo of Darbepoetin alfa" (1 trials) and "Placebo of Molidustat (BAY85-3934)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Asahikawa-Kosei General Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Asahikawa-Kosei General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Asahikawa-Kosei General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Asahikawa-Kosei General Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".